RVMD
Revolution Medicines, Inc.Healthcare$99.12
▼ Bearish
Mkt Cap: $19.64B|Float: 178.8M|SI: 8.1%|DTC: 6.4
Data as of market close Apr 2, 2026
IV Rank
10
IV Pctl
11%
HV 20d
37.6%
52W Range
$29-$124
ATR(14)
$3.56
Exp. Move
±13.0%
P/C Ratio
1.66
Earnings
May 6
GEX Negative
DEX Long
Net Call Premium
IV Low
Max Pain Below
Exp. Move Wide
High Put/Call
RVMD Key Options Data
- IV Rank
- 10.4%
- Total GEX
- $-0.00B
- Total DEX
- $2.8M
- Max Pain
- $90.00
- Expected Move
- ±13.0%
- Put/Call OI
- 1.66
- Net Premium
- $0.9M
- Spot Price
- $99.12
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$12.90 | ±13.0% | $86.22 | $112.02 |
| 2026-05-15 | 43 | ±$25.10 | ±25.3% | $74.02 | $124.22 |
| 2026-06-18 | 77 | ±$33.45 | ±33.8% | $65.67 | $132.57 |
| 2026-09-18 | 169 | ±$35.80 | ±36.1% | $63.32 | $134.92 |
| 2026-12-18 | 260 | ±$20.50 | ±20.7% | $78.62 | $119.62 |
| 2027-01-15 | 288 | ±$41.15 | ±41.5% | $57.97 | $140.27 |
Explore RVMD options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.